Clinical challenges: chemotherapy-induced peripheral neuropathy.
about
Integrated systems pharmacology analysis of clinical drug-induced peripheral neuropathy.Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment.Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScalePatterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivityA prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.Emotional Responses to Persistent Chemotherapy-induced Peripheral Neuropathy Experienced by Patients with Colorectal Cancer in Japan.The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.Cancer Chemotherapy in Early Life Significantly Alters the Maturation of Pain Processing.Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.
P2860
Q33733061-1A02723D-EBDA-49B6-818C-FF17560E1FE4Q35202129-E2BB755D-FFF7-4BBC-929E-C992E98A53CFQ35248222-CB54A08A-0745-4593-807D-982586DEB8EDQ35898310-30B78CAB-4952-4B7F-AF74-3760B008C309Q35898601-6DE2616D-E328-464F-A74F-22D7057E507CQ36117942-2931925A-8179-4E1A-9CA9-F7B45912B96EQ36176588-19001203-414E-4D8A-B151-7B9D258D0E8DQ36586687-C81BCD91-A535-4317-8F8E-5FC183B551B2Q38001374-53D3C984-F4F5-44E3-9BBF-9956FA86FE0EQ38684985-C7832F2E-D5A4-4780-A3A2-6B19213D50A3Q38700984-829B120F-C883-4FBA-BE2E-353E6B206DEDQ38993256-1850ED4B-9EF8-4657-B6D4-B7E1EDD4D616Q42119079-164BDDAE-AFA1-4565-9154-959429C3D07EQ45762363-27B3B90F-925B-4865-AC7A-DD5CCB091B4BQ47382359-D1D728FE-FE86-44EC-A279-0200740CB0B2Q50229022-0B343470-6001-4D02-8A20-97B3255F1099Q51000217-9F50B29B-F3BB-4530-8C97-C75654AFAB80
P2860
Clinical challenges: chemotherapy-induced peripheral neuropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@en
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@nl
type
label
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@en
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@nl
prefLabel
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@en
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@nl
P1476
Clinical challenges: chemotherapy-induced peripheral neuropathy.
@en
P356
10.1016/J.SONCN.2009.03.013
P433
P50
P577
2009-05-01T00:00:00Z